CRASH-2 Study of Tranexamic Acid to Treat Bleeding in Trauma Patients: A Controversy Fueled by Science and Social Media

This paper reviews the application of tranexamic acid, an antifibrinolytic, to trauma. CRASH-2, a large randomized controlled trial, was the first to show a reduction in mortality and recommend tranexamic acid use in bleeding trauma patients. However, this paper was not without controversy. Its pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Binz, Sophia, McCollester, Jonathon, Thomas, Scott, Miller, Joseph, Pohlman, Timothy, Waxman, Dan, Shariff, Faisal, Tracy, Rebecca, Walsh, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4576020/
https://www.ncbi.nlm.nih.gov/pubmed/26448897
http://dx.doi.org/10.1155/2015/874920

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4576020/
https://www.ncbi.nlm.nih.gov/pubmed/26448897
http://dx.doi.org/10.1155/2015/874920

Ejemplares similares